Detection of HPV infection by analyzing the changes 1n structure of peripheral blood lymphocytes specifically induced by HPV E7 antigen

Purpose: Detection of human papilloma virus (HPV) infection in clinical practice was examined based on the observation that peripheral blood lymphocytes exposed in vitro to antigenic or mitogenic stimulation change their intracellular structures as measured by polarization of fluorescent light emitted by labeled cells.

Materials and methods: A total of 47 women were enrolled in this study. They were classified into four groups based on the results of HPV-DNA detection in cervical tissues by the Hybrid Capture II kit (Digene, Gaithersburg, MD, USA) and pathological examination. Ten women with no HPV-DNA detection were used as a normal control group. Fifteen women without pathological diagnosis in the cervical tissues had HPV-DNA detection. Ten women with CIN lesions had 80% HPV-DNA detection. Twelve women with invasive squamous cell carcinoma had 100% HPV detection. Peripheral blood lymphocytes derived from all women were collected and then exposed to HPV-E7 antigen and PHA mitogen.

Results: The positive response rate of HPV-E7 antigen was ten percent (1/10) in the normal control group, 73.3% (11/15) in the HPV infectious women, 50% (5/10) in the CIN women, and 91.7% (11/12) in the cervical cancer patients. The overall sensitivity rate of blood tests was 77.1% and the specificity rate was 57.8% when the Hybrid Capture II HPV Test kit was used as the standard detection method for cervical tissue.

Conclusions: The results showed that peripheral blood lymphocytes derived from patients with cervical lesions might be another choice to be used as a screening method to detect HPV infection compared with conventional methods.

HPV; CIN; Cervical cancer

[1] Cercek L., Cercek B.: "Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a review." Eur. J. Cancer, 1977, 13, 903.

[2] Deutsch M.,R on I., Weinreb A., Tirosh R., Chaitchik S.: "Lymphocyte fluorescence polarization measurements with the CellScan system: application to the SCM cancer test". Cytometry, 1996, 23, 159.

[3] Kwasniewska A., Gozdzicka-Jozefiak A., Postawski K., Miturski R.: "Evaluation of DNA mismatch repair system in cervical dysplasias and invasive carcinomas related to HPV infection". Eur. J. Gynaecol. Oneal., 2002, 23, 231.

[4] Bekkers R. L. M., Melchers W. J. G., Bulten J., Boonstra H., Quint W. G. V., Hanselaar A. G. J. M., Massuger L. F. A. G.: "Localized distribution of human papillomavirus genotypes in the uterine cervix". Eur. J. Gynaecol. Oneal., 2002, 23, 203.

[5] Law K. S.,C hang T. C.,H sueh S.,J ung S. M.,T seng C. J.,L ai C. H.: "High prevalence of high grade squamous intraepithelial lesions and microinvasive carcinoma in women with a cytologic diagnosis of low grade squamous intraepithelial lesions". J Reprod. Med., 2001, 46, 61.

[6] Lin C. T., Tseng C. J., Lai C. H., Hsueh S., Huang H. J., Law K. S.: "High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or= 50 years of age". J. Reprod. Med., 2000, 45, 345.

[7] Juang C. M., Wang P. H., Yen M. S., Lai C. R., Ng H. T., Yuan C. C.: "Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage 1B and IIA squamous cell carcinoma of the uterine cervix". Gynecol. Oneal., 2000, 76, 103.

[8] Chao H. T.,W ang P.H.,T seng J. Y.,L ai C.R.,C hiang S. C.,Yu an C. C.: "Lymphocyte infiltrated on FIGO stage IIB squamous cell carcinoma of the cervix is a prominent factor for disease-free survival". Eur. J. Gynecol. Oneal., 1999, 20, 136.

[9] Wang P. H., Li Y. F., Juang C. M., Lee Y. R., Chao H. T., Tsai Y C., Yuan C. C.: "Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix". Gynecol. Oneal., 2001, 83, 121.

[10] Yuan C. C.,W ang P.H.,L ai C.R.,Y en M. S.,C hen C. Y.,J uang C. M.: "Prognosis-predicting system based on factors related to survival of cervical carcinoma". Int. J. Gynecol. Obstet., 1998, 63,163.

[11] Heim K., Widschwendter A., Pirschner G., Wieland U., Awerkiew S., Christensen N. D. et al.: "Antibodies to human papillomavirus 16 LI virus-like particles as an independent prognostic marker in cervical cancer". Am. J. Obstet. Gynecol., 2002, 186, 705.

[12] Silins I., Avall-Lundqvist E., Tadesse A., Jansen K. U., Stendahl U., Lenner P. et al.: "Evaluation of antibodies to human papillamavirus as prognostic markers in cervical cancer patients". Gynecol. Oneal., 2002, 85, 333.

[13] Merimsky O., Kaplan B., Deutsch M., Tirosh R., Chaitchik W. A.: "Detection of melanoma by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes". Cancer Det. Prev., 1996, 21, 167.

[14] Klein O., Lin S., Embon 0., Sazbon A., Zidan J., Kook A. I.: "An approach for high sensitivity detection of prostate cancer by analysis of changes in structure of the cytoplasmic matrix of lymphocytes specifically induced by psa-act". J. Ural., 1999, 161, 1994.

[15] Hennig E. M., Di Lonardo A., Venuti A., Holm R., Marcante M L., Nesland J. M.: "HPV 16 in multiple neoplastic lesions in women with CIN III". J. Exper. Clin. Cancer Res., 1999, 18, 369.

[16] Lertworapreecha M., Bhattarakosol P., Niruthisard S.: "Detection and typing of human papillomavirus in cervical intraepithelial neoplasia grade III in Thailand women". Southeast Asian J. Tropical Med. Public Health, 1998, 29, 507.

[17] Konno R.,P aez C., Sato S.,Yaj ima A.,F ukao A.: "HPV,h istologic grade and age. Risk factors for the progression of cervical intraepithelial neoplasia". J. Reprod. Med., 1998, 43, 561.

[18] Takac I., Marin J., Gorisek B.: "Human papillomavirus 16 and 18 infection of the uterine cervix in women with different grades of cervical intraepithelial neoplasia (CIN)". Int. J. Gynecol. Obstet., 1998, 61, 269.

[19] Arends M. J., Buckley C. H., Wells M.: "A etiology, pathogenesis, and pathology of cervical neoplasia". J. Clin. Pathol., 1998, 51, 96.

[20] Siritantikorn S., Laiwejpithaya S., Siripanyaphinyo U., Auewarakul P.,Y enchitsomanus P.,T hakernpol K.,W asi C.: "Detection and typing of human papilloma virus DNAs in normal cervix, intraepithelial neoplasia and cervical cancer in Bangkok". S.E. Asian J Tropical Med. Pub. Health, 1997, 28, 707.

[21] Klaes R., Woerner S. M.,R idder R., Wentzensen N., Duerst M., Schneider A. et al.: "Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes". Cancer Res., 1999, 59, 6132.